Trial Profile
Clinical Research; Efficacy of human atrial natriuretic peptide (hANP) on lung cancer surgery Basic Research; Efficacy of hANP on lung cancer
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 May 2016
Price :
$35
*
At a glance
- Drugs Carperitide (Primary)
- Indications Lung cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 16 Jan 2015 New trial record